Skip to main content
. Author manuscript; available in PMC: 2012 Aug 13.
Published in final edited form as: J Pediatr. 2011 Mar 1;159(2):308–13.e2. doi: 10.1016/j.jpeds.2011.01.018

Table 1.

Metabolic syndrome at age 24 and potential risk factors at age 14: race, free testosterone, estradiol, dehydroepiandrosterone sulfate, sex hormone binding globulin, oligomenorrhea (menses delay ≥42 days), metabolic syndrome, and childhood insulin

Age 14 variables n Median, interquartile range (IQ) Metabolic Syndrome Yes at age 24 (n=35) Metabolic Syndrome no at age 24 (n=385) Fisher’s p
WHITE (n=194)
FreeT (pg/ml) 194 1.16 (0.75, 1.63) 14% (2/14) in race-spec. top decile 8% (15/180) in race-spec. top decile .35
E2 (pg/ml) 194 76.7 (50.3, 135.8) 14% (2/14) in race-spec. bottom decile 7% (13/180) in race-spec. bottom decile .30
DHEAS (mcg/dl) 194 159.2 (109.1, 236.9) 14% (2/14) in race-spec. top decile 10% (18/180) in race-spec. top decile .64
SHBG (nmol/l) 194 18 (12, 24) 50% (7/14) in race-spec. bottom decile 8% (14/180) in race-spec. bottom decile .0001*
Insulin (uU/ml) 176 8.8 (5.6, 12.9) 42% (5/12) in race-spec. top decile 7% (11/164) in race-spec. top decile .0018*
Oligomenorrhea at age 14 153 12 Yes (8%) 18% (2/11) had oligomenorrhea 7% (10/142) had oligomenorrhea .21
MetS at age 14 194 11 Yes (6%) 36% (5/14) had MetS at age 14 3% (6/180) had MetS at age 14 .0003*
BLACK (n=226)
FreeT (pg/ml) 226 1.06 (0.65, 1.43) 29% (6/21) in race-spec. top decile 8% (17/205) in race-spec. top decile .011*
E2 (pg/ml) 225 90.7 (53.7, 187.5) 10% (2/21) in race-spec. bottom decile 10% (20/204) in race-spec. bottom decile 1.0
DHEAS (mcg/dl) 226 165.2 (117.1, 226) 14% (3/21) in race-spec. top decile 9% (19/205) in race-spec. top decile .44
SHBG (nmol/l) 226 17 (11, 24) 33% (7/21) in race-spec. bottom decile 7% (14/205) in race-spec. bottom decile .0011*
Insulin (uU/ml) 203 12.5 (7.9, 20.8) 40% (8/20) in race-spec. top decile 7% (13/183)) in race-spec. top decile .0002*
Oligomenorrhea at age 14 212 18 Yes (8%) 15% (3/20) had oligomenorrhea 8% (15/192) had oligomenorrhea .39
MetS at age 14 226 16 Yes (7%) 38% (8/21) had MetS at age 14 4% (8/205) had MetS at age 14 <.0001*
TOTAL COHORT (n=420)
Race 420 60% (21/35) black 53% (205/385) black .44
FreeT (pg/ml) 420 1.07 (0.71, 1.51) 23% (8/35) in race-spec. top decile 8% (32/385) in race-spec. top decile .011*
E2 (pg/ml) 419 84.9 (52.3, 160.8) 11% (4/35) in race-spec. bottom decile 9% (33/384) in race-spec. bottom decile .53
DHEAS (mcg/dl) 420 161.8 (115.3, 228.4) 14% (5/35) in race-spec. top decile 10% (37/385) in race-spec. top decile .38
SHBG (nmol/l) 420 17 (12, 24) 40% (14/35) in race-spec. bottom decile 7% (28/385) in race-spec. bottom decile <.0001*
Insulin (uU/ml) 379 10.5 (6.7, 16.4) 41% (13/32) in race-spec. top decile 7% (24/347) in race-spec. top decile <.0001*
Oligomenorrhea at age 14 365 30 Yes (8%) 16% (5/31) had oligomenorrhea 7% (25/334) had oligomenorrhea .16
MetS at age 14 420 27 Yes (6%) 37% (13/35) had MetS at age 14 4% (14/385) had MetS at age 14 <.0001*
*

significant using Hochberg-Benjamini method controlling for false discovery rate (p<.05), 7 tests in each race group, 8 tests in race-pooled group

Abbreviations: Free testosterone = FreeT, estradiol = E2, dehydroepiandrosterone sulfate = DHEAS, sex hormone binding globulin = SHBG, MetS = metabolic syndrome